Inpharma

Strategies for combating malaria
pp. 2-2(1)

Can money buy love in the pharmaceutical industry?
pp. 3-3(1)

Confidence in GP management of depression needs to be restored
pp. 3-3(1)

Fluoroquinolone use linked to multidrug-resistant bacteria in ICU
pp. 3-3(1)

Short-term transdermal fentanyl use common in The Netherlands
pp. 3-3(1)

TNF- inhibitors impose huge burden on Danish healthcare
pp. 4-4(1)

Herd immunity confers added cost benefit for pneumococcal vax
pp. 4-4(1)

Patients with migraine willing to fork out for drug that works well
pp. 4-4(1)

Pimecrolimus itching to prove its worth in atopic dermatitis
pp. 5-6(2)

Atorvastatin top of the class for hypercholesterolaemia in Spain
pp. 6-6(1)

Patients, caregivers more willing to pay for quick fix in schizophrenia
pp. 6-6(1)

Pnc9-MenC less immunogenic than MenC
pp. 7-7(1)

Istradefylline reduces off-time in advanced PD
pp. 7-7(1)

Lenalidomide + dexamethasone improves TTP in multiple myeloma
pp. 7-7(1)

Albumin IFN- fusion protein reduces viral load in HCV
pp. 7-7(1)

R&D news from the 61st Annual Meeting of the AAAAI
pp. 8-9(2)

Viramidine may induce a sustained virological response in HCV
pp. 9-9(1)

Ocaperidone exhibits antipsychotic activity in schizophrenia
pp. 10-10(1)

Valopicitabine [NM 283], in combination with peginterferon--2b, reduces viral load in patients with hepatitis C virus infection
pp. 10-10(1)

LB 80380 [ANA 380] has activity in patients with lamivudine-resistant hepatitis B virus (HBV) infections
pp. 10-10(1)

NC 503 [Fibrillex] may reduce disease progression in amyloid A amyloidosis
pp. 10-10(1)

Ranolazine reduces the frequency of angina attacks in patients receiving the maximum approved dose of amlodipine
pp. 10-10(1)

Nepafenac controls pain and postoperative inflammation following cataract surgery
pp. 10-10(1)

Ezetimibe/simvastatin a good combination in elderly, high risk patients
pp. 11-12(2)

Sirolimus-eluting stent at least as effective as CABG
pp. 12-12(1)

Atorvastatin induces atherosclerotic plaque regression
pp. 13-13(1)

Intermittent corticosteroids viable treatment for mild persistent asthma
pp. 13-13(1)

Add abciximab to angioplasty, not fibrinolysis, in STEMI
pp. 13-13(1)

A combination of melphalan, arsenic trioxide and ascorbic acid [vitamin C] reduces serum M-protein levels in multiple myeloma
pp. 13-13(1)

Cardiac resynchronisation improves symptoms in HF, dyssynchrony
pp. 14-14(1)

Pre-CMF doxorubicin and post-CMF goserelin/tamoxifen a breast ahead
pp. 14-14(1)

Perindopril prevents progression in Duchenne muscular dystrophy
pp. 14-14(1)

Simvastatin + fenofibrate sends hyperlipidaemia packing
pp. 14-14(1)

MVP active in metastatic breast cancer
pp. 15-15(1)

Desloratadine/pseudoephedrine clears the way in SAR
pp. 15-15(1)

Leflunomide eases juvenile rheumatoid arthritis
pp. 15-15(1)

Gemcitabine + docetaxel an option in advanced NSCLC?
pp. 15-15(1)

Adjunctive treatment with levetiracetam is effective and safe in idiopathic generalised epilepsy with myoclonic seizures
pp. 15-15(1)

Ciprofloxacin suppresses urinary BKV reactivation after HSCT
pp. 16-16(1)

Prevenar "highly immunogenic" in young children
pp. 16-16(1)

Montelukast improves SCORing Atopic Dermatitis (SCORAD) scores in paediatric patients with atopic dermatitis
pp. 16-16(1)

Bexarotene active in alopecia areata
pp. 16-16(1)

Retreatment with peginterferon--2b plus ribavirin is effective in some treatment-refractory patients with chronic hepatitis C
pp. 16-16(1)

Ropivacaine longer lasting in regional anaesthesia
pp. 17-17(1)

Docetaxel + estramustine + prednisone has "significant impact"
pp. 17-17(1)

3 days of azithromycin sufficient for bronchitis exacerbation
pp. 17-17(1)

Ezetimibe/simvastatin scores more goals than atorvastatin
pp. 17-17(1)

Neoadjuvant trastuzumab promising in breast cancer
pp. 18-18(1)

Esomeprazole beats pantoprazole for erosive oesophagitis
pp. 18-18(1)

Fondaparinux ASPIREs to prevent complications during PCI
pp. 18-18(1)

Meloxicam, naproxen comparable for JRA
pp. 18-18(1)

Zofenopril is as effective as lisinopril in the treatment of elderly patients with mild-to-moderate hypertension
pp. 19-19(1)

Once-daily ciclesonide maintains asthma control
pp. 19-19(1)

Trimetazidine plus sildenafil is more effective than isosorbide mononitrate monotherapy in controlling episodes of myocardial ischaemia during sexual activity
pp. 19-19(1)

Pneumococcal vaccination substantially reduces mortality due to invasive pneumococcal (IPD) disease in children aged < 2 years
pp. 19-19(1)

Nimodipine may be of some benefit in the treatment of patients with subcortical vascular dementia
pp. 19-19(1)

Adherence to therapy provided free of charge tends to be greater for tacrolimus than for ciclosporin among renal transplant recipients
pp. 19-19(1)

Amoxicillin, doxycycline don't affect NuvaRing pharmacokinetics
pp. 20-20(1)

Donepezil, tocopherol do not slow long-term progression to AD
pp. 20-20(1)

SC lidocaine and, to a lesser extent, topical lidocaine may have reduced analgesic efficacy in women with red hair
pp. 20-20(1)

Dexamethasone-eluting stent reduces CRP levels after PCI
pp. 20-20(1)

Tocopherol increases risk of second primary cancer
pp. 21-21(1)

The measles mumps and rubella (MMR) virus vaccine does not appear to be associated with an increase in Crohn's disease
pp. 21-21(1)

Trileptal label updated in the US to reflect new safety information
pp. 21-21(1)

Celecoxib associated with similar cardiovascular risk to rofecoxib
pp. 21-21(1)

Other US regulatory news
pp. 22-22(1)

Manufacturing approvals in Japan
pp. 22-22(1)

The EU's Committee for Medicinal Products for Human Use (CHMP) has given positive opinions to new indications for aprepitant [Emend; Merck & Co] and bortezomib [Velcade; Johnson & Johnson]
pp. 22-22(1)

Reminyl renamed Razadyne in US
pp. 22-22(1)

Pfizer is withdrawing Bextra [valdecoxib] from the New Zealand (NZ) market voluntarily
pp. 22-22(1)

US product approvals
pp. 23-23(1)